Market News

$-0.15 EPS Expected for Novavax, Inc. (NVAX); Manchester United Limited (MANU) Shorts Up By 1.93%

Manchester United Limited (NYSE:MANU) had an increase of 1.93% in short interest. MANU’s SI was 317,100 shares in February as released by FINRA. Its up 1.93% from 311,100 shares previously. With 109,500 avg volume, 3 days are for Manchester United Limited (NYSE:MANU)’s short sellers to cover MANU’s short positions. The SI to Manchester United Limited’s float is 0.99%. The stock decreased 2.24% or $0.45 during the last trading session, reaching $19.65. About 24,737 shares traded. Manchester United plc (NYSE:MANU) has risen 0.85% since February 14, 2017 and is uptrending. It has underperformed by 15.85% the S&P500.

Analysts expect Novavax, Inc. (NASDAQ:NVAX) to report $-0.15 EPS on February, 26.They anticipate $0.06 EPS change or 28.57% from last quarter’s $-0.21 EPS. After having $-0.15 EPS previously, Novavax, Inc.’s analysts see 0.00% EPS growth. The stock decreased 1.00% or $0.02 during the last trading session, reaching $1.99. About 3.30 million shares traded. Novavax, Inc. (NASDAQ:NVAX) has declined 79.61% since February 14, 2017 and is downtrending. It has underperformed by 96.31% the S&P500.

Investors sentiment decreased to 1.25 in Q3 2017. Its down 0.13, from 1.38 in 2017Q2. It worsened, as 6 investors sold Manchester United plc shares while 10 reduced holdings. 8 funds opened positions while 12 raised stakes. 33.50 million shares or 17.03% more from 28.62 million shares in 2017Q2 were reported. Millennium Management Limited Company stated it has 30,806 shares. Citadel Advsr Ltd Liability Com has 0% invested in Manchester United plc (NYSE:MANU). California Employees Retirement Sys holds 0% of its portfolio in Manchester United plc (NYSE:MANU) for 40,300 shares. Lansdowne Prtnrs (Uk) Llp holds 4.94 million shares. Bancshares Of Montreal Can has invested 0% in Manchester United plc (NYSE:MANU). Gabelli Funds Ltd Llc reported 0% of its portfolio in Manchester United plc (NYSE:MANU). Lomas Mngmt Limited Co holds 1.93% of its portfolio in Manchester United plc (NYSE:MANU) for 534,836 shares. 100 are held by Focused Wealth Inc. Pnc Services holds 0% or 100 shares. Jpmorgan Chase And has invested 0% of its portfolio in Manchester United plc (NYSE:MANU). Blackrock, a New York-based fund reported 137,531 shares. Goldman Sachs Grp Inc owns 31,323 shares. Assetmark holds 0% or 4 shares in its portfolio. Kj Harrison & Prtn Inc holds 51,010 shares or 0.32% of its portfolio. Deutsche Bankshares Ag invested in 0% or 21,734 shares.

Manchester United plc, together with its subsidiaries, owns and operates a professional sports team in the United Kingdom. The company has market cap of $3.23 billion. The firm operates Manchester United Football Club, a professional football club. It currently has negative earnings. It develops marketing and sponsorship relationships with regional and international companies to leverage its brand.

Among 5 analysts covering Manchester United Ltd. (NYSE:MANU), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Manchester United Ltd. had 14 analyst reports since September 18, 2015 according to SRatingsIntel. Jefferies maintained Manchester United plc (NYSE:MANU) rating on Monday, September 18. Jefferies has “Buy” rating and $19.0 target. Gabelli initiated the shares of MANU in report on Monday, October 17 with “Buy” rating. The rating was maintained by Jefferies with “Buy” on Friday, September 22. The rating was maintained by Jefferies on Monday, August 14 with “Buy”. Credit Suisse maintained it with “Outperform” rating and $20 target in Tuesday, March 15 report. The firm has “Buy” rating by Jefferies given on Friday, September 18. As per Thursday, November 16, the company rating was maintained by Jefferies. The firm has “Buy” rating given on Monday, June 5 by Jefferies. On Tuesday, August 16 the stock rating was maintained by Jefferies with “Buy”.

Among 12 analysts covering Novavax (NASDAQ:NVAX), 4 have Buy rating, 0 Sell and 8 Hold. Therefore 33% are positive. Novavax had 26 analyst reports since August 11, 2015 according to SRatingsIntel. JP Morgan downgraded the shares of NVAX in report on Friday, September 16 to “Neutral” rating. The rating was upgraded by Ladenburg Thalmann on Wednesday, August 9 to “Buy”. The stock has “Buy” rating by Citigroup on Tuesday, October 31. The company was maintained on Tuesday, September 20 by Chardan Capital Markets. The firm earned “Hold” rating on Monday, July 24 by Piper Jaffray. Piper Jaffray maintained Novavax, Inc. (NASDAQ:NVAX) rating on Tuesday, September 19. Piper Jaffray has “Hold” rating and $1.5 target. The firm earned “Neutral” rating on Monday, April 4 by Chardan Capital Markets. The stock has “Outperform” rating by FBR Capital on Friday, September 16. The firm earned “Buy” rating on Thursday, January 11 by FBR Capital. The firm has “Hold” rating by Cantor Fitzgerald given on Friday, July 21.

Investors sentiment increased to 1.26 in 2017 Q3. Its up 0.24, from 1.02 in 2017Q2. It improved, as 10 investors sold Novavax, Inc. shares while 29 reduced holdings. 14 funds opened positions while 35 raised stakes. 113.94 million shares or 6.86% less from 122.33 million shares in 2017Q2 were reported. Weiss Asset Lp holds 0% of its portfolio in Novavax, Inc. (NASDAQ:NVAX) for 11,916 shares. Moreover, State Street has 0% invested in Novavax, Inc. (NASDAQ:NVAX). Citigroup, a New York-based fund reported 124,212 shares. Tiaa Cref Management Limited Co reported 0% of its portfolio in Novavax, Inc. (NASDAQ:NVAX). D E Shaw Inc accumulated 446,101 shares. Prudential Fincl invested 0% in Novavax, Inc. (NASDAQ:NVAX). Canada Pension Plan Board invested 0% of its portfolio in Novavax, Inc. (NASDAQ:NVAX). Financial Bank Of America De invested in 390,357 shares. Edgemoor Investment Advsr has invested 0.01% in Novavax, Inc. (NASDAQ:NVAX). Barry Invest Advsr Ltd Llc has invested 0.01% of its portfolio in Novavax, Inc. (NASDAQ:NVAX). Swiss Natl Bank holds 447,050 shares or 0% of its portfolio. Franklin Resources owns 3.43 million shares for 0% of their portfolio. Washington Tru Comm holds 0% in Novavax, Inc. (NASDAQ:NVAX) or 24,700 shares. Credit Suisse Ag accumulated 0% or 1.25 million shares. Jpmorgan Chase And Company holds 0% in Novavax, Inc. (NASDAQ:NVAX) or 6.20 million shares.

Since August 31, 2017, it had 1 insider purchase, and 1 sale for $173,620 activity. Glenn Gregory M had bought 12,784 shares worth $11,250. Shares for $184,870 were sold by YOUNG JAMES F.

Novavax, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants. The company has market cap of $643.23 million. The firm develops respiratory syncytial virus fusion protein nanoparticle vaccine candidate for infants via maternal immunization in Phase III development stage; older adults in Phase II development stage; and children six months to five years of age in Phase I development stage. It currently has negative earnings. It also develops Ebola GP vaccine in Phase 1 clinical trial; preclinical programs for Zika virus; and seasonal influenza and a combination respiratory vaccine candidate, as well as other infectious disease vaccine candidates.

Leave a Reply

Your email address will not be published. Required fields are marked *